These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29552120)

  • 1. The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and α-SMA.
    Fang M; Yuan J; Chen M; Sun Z; Liu L; Cheng G; Ying H; Yang S; Chen M
    Oncol Lett; 2018 Apr; 15(4):4805-4812. PubMed ID: 29552120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognostic analysis of hepatocellular carcinoma based on the tumor neo-vessels, macrophages and α-SMA in tumor microenvironment].
    Fang M; Yuan JP; Liu LL; Cheng GP; Ying HJ; Chen YM; Chen M
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):518-523. PubMed ID: 28728298
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic Analysis of NSCLC Based on the Tumor-associated Macrophages, Tumor Neo-vessels and PD-L1 Expression in Tumor Microenvironment].
    Hang Q; Ying H; Cheng G; Yang S; Jin J; Chen Y; Chen Q; Jiang Y; Zhao Q; Fang M; Chen M; Lai X
    Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):837-844. PubMed ID: 33070512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 5. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
    Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
    Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated tumor stromal features of hepatocellular carcinoma reveals two distinct subtypes with prognostic/predictive significance.
    Li W; Han J; Yuan K; Wu H
    Aging (Albany NY); 2019 Jul; 11(13):4478-4509. PubMed ID: 31299011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of expression of Myc-induced nuclear antigen 53 in hepatocellular carcinoma and its relationship with patient prognosis].
    Ye DX; Zhou X; Yang Q; Hu XY; Li H; Xiang FG
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):259-265. PubMed ID: 32306660
    [No Abstract]   [Full Text] [Related]  

  • 11. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value.
    Ren CX; Leng RX; Fan YG; Pan HF; Li BZ; Wu CH; Wu Q; Wang NN; Xiong QR; Geng XP; Ye DQ
    Oncol Rep; 2017 Aug; 38(2):886-898. PubMed ID: 28656201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-evolution of tumor-associated macrophages and tumor neo-vessels during cervical cancer invasion.
    Jiang S; Yang Y; Fang M; Li X; Yuan X; Yuan J
    Oncol Lett; 2016 Oct; 12(4):2625-2631. PubMed ID: 27698836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
    Jin J; Zhu P; Liao Y; Li J; Liao W; He S
    Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of smooth muscle calponin in tumor vessels of human hepatocellular carcinoma and its possible association with prognosis.
    Sasaki Y; Yamamura H; Kawakami Y; Yamada T; Hiratsuka M; Kameyama M; Ohigashi H; Ishikawa O; Imaoka S; Ishiguro S; Takahashi K
    Cancer; 2002 Mar; 94(6):1777-86. PubMed ID: 11920541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of tumor/stroma interactions in prognosis of hepatocellular carcinoma.
    Eiró N; Vizoso FJ
    Hepatobiliary Surg Nutr; 2014 Apr; 3(2):98-101. PubMed ID: 24812604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage profile in primary versus secondary liver tumors.
    Avădănei ER; Wierzbicki PM; Giuşcă SE; Grigoraş A; Amălinei C; Căruntu ID
    Folia Histochem Cytobiol; 2014; 52(2):112-23. PubMed ID: 25007179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma.
    Chen L; Chen M; Han Z; Jiang F; Xu C; Qin Y; Ding N; Liu Y; Zhang T; An Z; Guo C
    J Clin Pathol; 2018 Aug; 71(8):721-728. PubMed ID: 29559517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
    Resende U; Cabello C; Ramalho SOB; Zeferino LC
    BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.